2023 Tennessee Code
Title 39 - CRIMINAL OFFENSES (§§ 39-1-101 — 39-17-1812)
Chapter 17 - OFFENSES AGAINST PUBLIC HEALTH, SAFETY AND WELFARE (§§ 39-17-101 — 39-17-1812)
Part 4 - DRUGS (§§ 39-17-401 — 39-17-456)
Section 39-17-406 - Controlled substances in Schedule I

• (a) Schedule I consists of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section.

• (b) Opiates, unless specifically excepted or unless listed in another schedule, means any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation; provided, that for the purposes of subdivision (b)(48)(B)(xv), 3-Methylfentanyl, only, "isomer" includes the optical and geometric isomers:
  • (1) Acetylmethadol;
  • (2) Allylprodine;
  • (3) Alphacetylmethadol (except levo-alphacetylmethadol, also known as levo-alpha-acetylmethadol; levomethadyl acetate; or LAAM);
  • (4) Alphameprodine;
  • (5) Alphamethadol;
  • (6) Benzethidine;
  • (7) Betacetylmethadol;
  • (8) Betameprodine;
  • (9) Betamethadol;
  • (10) Betaprodine;
  • (11) Clonitazene;
  • (12) Dextromoramide;
  • (13) Diampromide;
  • (14) Diethylthiambutene;
  • (15) Difenoxin;
  • (16) Dimenoxadol;
  • (17) Dimepheptanol;
  • (18) Dimethylthiambutene;
  • (19) Dioxaphetyl butyrate;
  • (20) Dipipanone;
  • (21) Ethylmethylthiambutene;
  • (22) Etonitazene;
  • (23) Etoxeridine;
  • (24) Furethidine;
  • (25) Hydroxypethidine;
  • (26) Ketobemidone;
  • (27) Levomoramide;
  • (28) Levophenacylmorphan;
  • (29) Morpheridine;
  • (30) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
  • (31) Noracymethadol;
  • (32) Norlevorphanol;
  • (33) Normethadone;
  • (34) Norpipanone;
  • (35) PEPAP (1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine);
  • (36) Phenadoxone;
  • (37) Phenampromide;
  • (38) Phenomorphan;
  • (39) Phenoperidine;
  • (40) Piritramide;
  • (41) Proheptazine;
  • (42) Properidine;
  • (43) Propiram;
  • (44) Racemoramide;
  • (45) Tilidine;
  • (46) Trimeperidine;
  • (47) U-47700; or
  • (48) Fentanyl derivatives and analogues:
    • (A) Unless specifically excepted, listed in another schedule, or contained within a pharmaceutical product approved by the United States food and drug administration, any material, compound, mixture, or preparation, including its salts, isomers, esters, or ethers, and salts of isomers, esters, or ethers, whenever the existence of such salts is possible within any of the following specific chemical designations containing a 4-anilidopiperidine structure:
      • (i) With or without substitution at the carbonyl of the aniline moiety with alkyl, alkenyl, carboalkoxy, cycloalkyl, methoxyalkyl, cyanoalkyl, or aryl groups, or furanyl, dihydrofuranyl, benzyl moiety, or rings containing heteroatoms sulfur, oxygen, or nitrogen;
      • (ii) With or without substitution at the piperidine amino moiety with a phenethyl, benzyl, alkylaryl (including heteroaromatics), alkyltetrazolyl ring, or an alkyl or carbomethoxy group, whether or not further substituted in the ring or group;
      • (iii) With or without substitution or addition to the piperdine ring to any extent with one or more methyl, carbomethoxy, methoxy, methoxymethyl, aryl, allyl, or ester groups;
      • (iv) With or without substitution of one or more hydrogen atoms for halogens, or methyl, alkyl, or methoxy groups, in the aromatic ring of the anilide moiety;
      • (v) With or without substitution at the alpha or beta position of the piperidine ring with alkyl, hydroxyl, or methoxy groups;
      • (vi) With or without substitution of the benzene ring of the anilide moiety for an aromatic heterocycle; or
      • (vii) With or without substitution of the piperidine ring for a pyrrolidine ring, perhydroazepine ring, or azepine ring; and
    • (B) The application of subdivision (b)(48)(A) includes, but is not limited to, any of the following:
      • (i) Acetylfentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide);
      • (ii) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidnyl]-N-phenyl-acetamide);
      • (iii) Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide);
      • (iv) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido)piperidine);
      • (v) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
      • (vi) Benzodioxolefentanyl;
      • (vii) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide);
      • (viii) Beta-hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide); N-[1-[2-hydroxy-2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenylpropanamide);
      • (ix) Beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide);
      • (x) Butyrylfentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide; N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide);
      • (xi) Cyclopentyl fentanyl;
      • (xii) Isobutyryl fentanyl;
      • (xiii) Furanyl fentanyl;
      • (xiv) Lofentanil;
      • (xv) 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide);
      • (xvi) 3-Methylthiofentanyl (N-[3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
      • (xvii) Ocfentanil;
      • (xviii) Ohmefentanyl;
      • (xix) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl] propanamide);
      • (xx) Para-fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide; 4-fluoroisobutyryl fentanyl;
      • (xxi) Pentanoyl fentanyl;
      • (xxii) Thiofentanyl; or
      • (xxiii) Valeryl fentanyl.

• (c) Opium derivatives, unless specifically excepted or unless listed in another schedule, means any of the following opium derivatives, its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
  • (1) Acetorphine;
  • (2) Acetyldihydrocodeine;
  • (3) Benzylmorphine;
  • (4) Codeine methylbromide;
  • (5) Codeine-N-Oxide;
  • (6) Cyprenorphine;
  • (7) Desomorphine;
  • (8) Dihydromorphine;
  • (9) Drotebanol;
  • (10) Etorphine (except hydrochloride salt);
  • (11) Heroin;
  • (12) Hydromorphinol;
  • (13) Methyldesorphine;
  • (14) Methyldihydromorphine;
  • (15) Morphine methylbromide;
  • (16) Morphine methylsulfonate;
  • (17) Morphine-N-Oxide;
  • (18) Myrophine;
  • (19) Nicocodeine;
  • (20) Nicomorphine;
  • (21) Normorphine;
  • (22) Pholcodine; or
  • (23) Thebacon.

• (d) Hallucinogenic substances, unless specifically excepted or unless listed in another schedule, means any material, compound mixture, or preparation that contains any quantity of the following hallucinogenic substances, or that contains any of its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specified chemical designation; provided, that for purposes of this subsection (d) only, "isomer" includes the optical, positional, and geometric isomers:
  • (1) Alpha-ethyltryptamine

    Other names: etryptamine; Monase; [alpha]-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; [alpha]-ET; and AET; ET; Trip;

  • (2) Alpha-methyltryptamine

    Other name: AMT;

  • (3) 4-Bromo-2,5-dimethoxyamphetamine

    Other names: 4-Bromo-2,5-dimethoxy-[alpha]-methylphenethylamine; 4-bromo-2,5-DMA;

  • (4) 4-Bromo-2,5-dimethoxyphenethylamine

    Other names: 2-(4-Bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B; Nexus;

  • (5) 2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine

    Other names: 25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36;

  • (6) Bufotenine

    Other names: 3-([beta]-Dimethylaminoethyl)-5-hydroxyindole; 3-(2 dimethylaminoethyl)-5-indolol; N,N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine;

  • (7) 2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine

    Other names: 25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82;

  • (8) Diethyltryptamine

    Other names: N,N-Diethyltryptamine; DET;

  • (9) 2,5-Dimethoxyamphetamine

    Other names: 2,5-Dimethoxy-[alpha]-methylphenethylamine; 2,5-DMA;

  • (10) 2,5-Dimethoxy-4-ethylamphetamine

    Other name: DOET;

  • (11) 2,5 Dimethoxy-4-(n)-propylthiophenethylamine

    Other name: 2C-T-7;

  • (12) Dimethyltryptamine

    Other name: DMT;

  • (13) Ethylamine analogue of phencyclidine

    Other names: N-Ethyl-1-phenylcyclohexylamine; (1-phenylcyclohexyl)ethylamine; N-(1-phenylcyclohexyl)ethylamine; cyclohexamine; PCE;

  • (14) Ibogaine

    Other names: 7-Ethyl-6,6[beta],7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1',2':1,2]azepino[5,4-b]indole; Tabenanthe iboga;

  • (15) 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine

    Other names: 25I-NBOMe; 2C-I-NBOMe; 25I; Cimbi-5;

  • (16) Lysergic acid diethylamide

    Other name: LSD;

  • (17) Mescaline

    Other name: Constituent of "Peyote" cacti;

  • (18) 4-Methoxyamphetamine

    Other names: 4-methoxy-[alpha]-methylphenethylamine; paramethoxyamphetamine; PMA;

  • (19) 5-Methoxy-3,4-methylenedioxyamphetamine;
  • (20) 5-Methoxy-N,N-diisopropyltryptamine

    Other name: 5-MeO-DIPT;

  • (21) 5-methoxy-N,N-dimethyltryptamine

    Other names: 5-methoxy-3-[2-(dimethylamino)ethyl]indole; 5-MeO-DMT;

  • (22) 4-Methyl-2,5-dimethoxyamphetamine

    Other names: 4-methyl-2,5-dimethoxy-[alpha]-methylphenethylamine; DOM; STP;

  • (23) 3,4-Methylenedioxyamphetamine;
  • (24) 3,4-Methylenedioxymethamphetamine

    Other name: MDMA;

  • (25) 3,4-Methylenedioxy-N-ethylamphetamine

    Other names: N-ethyl-alpha-methyl 3,4(methylenedioxy) phenethylamine; N-ethyl MDA; MDE; MDEA;

  • (26) 3,4-Methylenedioxy-N-methylcathinone

    Other name: Methylone;

  • (27) N-Ethyl-3-piperidyl benzilate;
  • (28) N-Hydroxy-3,4-methylenedioxyamphetamine

    Other names: N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine; N-hydroxy MDA;

  • (29) N-methyl-3-piperidyl benzilate;
  • (30) Parahexyl

    Other names: 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl;

  • (31) Peyote

    Meaning all parts of the plant presently classified botanically as Lophophora williamsii Lamaire, whether growing or not, the seeds thereof, any extract from any part of such plant, and every compound, manufacture, salts, derivative, mixture, or preparation of such plant or its seeds or extracts (Interprets 21 U.S.C. § 812(c), Schedule l(c)(12));

  • (32) Psilocybin (constituent of magic mushrooms);
  • (33) Psilocyn (constituent of magic mushrooms);
  • (34) Pyrrolidine analogue of phencyclidine (1-(1-phenylcyclohexyl)-pyrrolidine)

    Other names: PCPy; PHP;

  • (35) 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine

    Other name: TCPy;

  • (36) 4-Methylmethcathinone

    Other names: mephedrone; methpadrone; 4-MMC;

  • (37) 3,4-Methylenedioxypyrovalerone

    Other name: MDPV;

  • (38) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E);
  • (39) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D);
  • (40) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C);
  • (41) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I);
  • (42) 2-[4-Ethylthio-2,5-dimethoxyphenyl]ethanamine (2C-T-2);
  • (43) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4);
  • (44) 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H);
  • (45) 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N);
  • (46) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P);
  • (47) Thiophene analogue of phencyclidine

    Other names: 1-[1-(2-thienyl)cyclohexyl]piperidine; 2-thienylanalog of phencyclidine; TPCP; TCP;

  • (48) 3,4,5-Trimethoxyamphetamine;
  • (49) (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone

    Other names: UR-144; 1-pentyl-3-(2,2,3,3 tetramethylcyclopropoyl)indole; or

  • (50) [1-(5-Fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl) methanone

    Other names: 5-fluoro-UR-144; 5-F-UR-144; XLR-11 1-(5-fluoro-pentyl)-3- (2,2,3,3-tetramethylcyclopropoyl)indole.

• (e) Depressants, unless specifically excepted or unless listed in another schedule, means any material, compound, mixture, or preparation that contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specified chemical designation:
  • (1) Etizolam

    Other names: Etilaam, Etizola, Sedekopan, Pasaden, Depas;

  • (2) Gamma-hydroxybutyric acid

    Other names: GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate;

  • (3) Mecloqualone; or
  • (4) Methaqualone.

• (f) Stimulants, unless specifically excepted or unless listed in another schedule, means any material, compound, mixture, or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:
  • (1) Alpha-pyrrolidinobutiophenone

    Other names: [alpha]-PBP; 1-phenyl-2-(pyrrolidin-1-yl)butan-1-one;

  • (2) Alpha-pyrrolidinopentiophenone

    Other names: [alpha]-PVP; [alpha]-pyrrolidinovalerophenone; 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one;

  • (3) Aminorex

    Other names: aminoxophen; 2-amino-5-phenyl-2-oxazoline; or 4,5-dihydro-5-phenyl-2-oxazolamine;

  • (4) Butylone

    Other names: bk-MBDB; 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one;

  • (5) Cathinone

    Other names: 2-amino-1-phenyl-1-propanone; alpha-aminopropiophenone; 2-aminopropiophenone; norphedrone; constituent of catha edulis or "Khat" plant;

  • (6) 3-Fluoro-N-methylcathinone

    Other names: 3-FMC; 1-(3-fluorophenyl)-2-(methylamino)propan-1-one;

  • (7) 4-Fluoro-N-methylcathinone

    Other names: 4-FMC; flephedrone; 1-(4-fluorophenyl)-2-(methylamino)propan-1-one;

  • (8) Fenethylline;
  • (9) Methcathinone

    Other names: 2-(methylamino)-propiophenone; alpha-(methylamino) propiophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR1432;

  • (10) (+/-)cis-4-Methylaminorex (cis isomer)

    Other name: (+/-)cis-4,5 dihydro-4-methyl-5-phenyl-2-oxazolamine;

  • (11) 4-Methyl-N-ethylcathinone

    Other names: 4-MEC; 2-(ethylamino)-1-(4-methylphenyl)propan-1-one;

  • (12) 4-Methyl-alpha-pyrrolidinopropiophenone

    Other names: 4-MePPP; MePPP; 4-methyl-[alpha]-pyrrolidinopropiophenone; 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)-propan-1-one;

  • (13) Naphyrone

    Other names: naphthylpyrovalerone; 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one;

  • (14) N-Benzylpiperazine

    Other names: BZP; 1-benzylpiperazine;

  • (15) N-Ethylamphetamine;
  • (16) N,N-Dimethylamphetamine

    Other names: N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine;

  • (17) Pentedrone

    Other names: [alpha]-methylaminovalerophenone; 2-(methylamino)-1-phenylpentan-1-one; or

  • (18) Pentylone

    Other names: bk-MBDP; 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one.

• (g) Cannabimimetic agents, unless specifically exempted or unless listed in another schedule, means any material, compound, mixture, or preparation that contains any quantity of the following substances, or that contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
  • (1) 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP-47,497);
  • (2) 5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol or CP-47,497 C8-homolog);
  • (3) 1-Pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678);
  • (4) 1-Butyl-3-(1-naphthoyl)indole (JWH-073);
  • (5) 1-Hexyl-3-(1-naphthoyl)indole (JWH-019);
  • (6) 1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200);
  • (7) 1-Pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250);
  • (8) 1-Pentyl-3-[1-(4-methoxynaphthoyl)]indole (JWH-081);
  • (9) 1-Pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122);
  • (10) 1-Pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398);
  • (11) (1-(5-Fluoropentyl)-1H-indazol-3-yl)(naphthalen-1-yl)methanone (THJ-2201);
  • (12) 1-(5-Fluoropentyl)-3-(1-naphthoyl)indole (AM2201);
  • (13) 1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole (AM694);
  • (14) 1-Pentyl-3-[(4-methoxy)-benzoyl]indole (SR-19 and RCS-4);
  • (15) 1-Cyclohexylethyl-3-(2-methoxyphenylacetyl)indole (SR-18 and RCS-8);
  • (16) 1-Pentyl-3-(2-chlorophenylacetyl)indole (JWH-203);
  • (17) Methyl 2-(1-(cyclohexylmethyl)-1h-indole-3-carboxamido)-3,3-dimethylbutanoate

    Other names: MDMB-CHMICA, MMB-CHMINACA;

  • (18) Methyl 2-(1-(4-fluorobenzyl)-1h-indazole-3-carboxamido)-3,3-dimethylbutanoate

    Other name: MDMB-FUBINACA;

  • (19) Methyl 2-(1-(5-fluoropentyl)-1h-indazole-3-carboxamido)-3-methylbutanoate

    Other name: 5F-AMB;

  • (20) Methyl 2-(1-(5-fluoropentyl)-1h-indazole-3-carboxamido)-3,3-dimethylbutanoate

    Other names: 5F-ADB, 5F-MDMB-PINACA;

  • (21) N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide

    Other names: APINACA; AKB48;

  • (22) N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide

    Other names: 5F-APINACA, 5F-AKB48;

  • (23) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide

    Other name: AB-FUBINACA;

  • (24) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1(cyclohexylmethyl)-1H-indazole-3-carboxamide

    Other name: AB-CHMINACA;

  • (25) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)1H-indazole-3-carboxamide

    Other name: ADB-FUBINACA;

  • (26) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide

    Other name: ADB-PINACA;

  • (27) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide

    Other name: AB-PINACA;

  • (28) Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate

    Other names: 5-fluoro-PB-22; 5F-PB-22; or

  • (29) Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate

    Other names: PB-22; QUPIC.

Amended by 2018 Tenn. Acts, ch. 1040,s 3, eff. 7/1/2018.

Amended by 2015 Tenn. Acts, ch. 302,s 1, eff. 7/1/2015.

Amended by 2014 Tenn. Acts, ch. 735,s 2, eff. 7/1/2014.

Acts 1989, ch. 591, § 1; 1997, ch. 107, § 1; 1997, ch. 149, § 1; 2007, ch. 298, §§ 1-4; 2012, ch. 812, § 1.